SNDL Future Growth

Future criteria checks 1/6

SNDL is forecast to grow earnings and revenue by 146.1% and 7.2% per annum respectively while EPS is expected to grow by 73.1% per annum.

Key information

146.1%

Earnings growth rate

73.1%

EPS growth rate

Pharmaceuticals earnings growth	21.6%
Revenue growth rate	7.2%
Future return on equity	n/a
Analyst coverage	Low
Last updated	06 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:VY4 - Analysts future estimates and past financials data (CAD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	1,026	N/A	N/A	N/A	1
12/31/2025	955	-2	16	55	2
12/31/2024	914	-34	4	42	2
9/30/2024	911	-110	34	44	N/A
6/30/2024	912	-113	40	49	N/A
3/31/2024	916	-136	26	35	N/A
12/31/2023	909	-168	-25	-17	N/A
9/30/2023	901	-211	-11	-1	N/A
6/30/2023	894	-287	-29	-20	N/A
3/31/2023	886	-331	-41	-29	N/A
12/31/2022	712	-335	-18	-7	N/A
9/30/2022	495	-266	-38	-30	N/A
6/30/2022	278	-151	-101	-95	N/A
3/31/2022	64	-130	-152	-147	N/A
12/31/2021	56	-227	-160	-156	N/A
9/30/2021	47	-228	-176	-173	N/A
6/30/2021	46	-316	-140	-137	N/A
3/31/2021	57	-296	-80	-78	N/A
12/31/2020	61	-200	-61	-57	N/A
9/30/2020	62	-170	-123	-101	N/A
6/30/2020	77	-184	-157	-109	N/A
3/31/2020	76	-164	-189	-107	N/A
12/31/2019	64	-143	-223	-113	N/A
9/30/2019	49	-156	-200	-75	N/A
6/30/2019	21	-84	-181	-49	N/A
3/31/2019	1	-77	-167	-49	N/A
12/31/2018	N/A	-68	-122	-31	N/A
2/28/2018	N/A	-13	N/A	-5	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VY4 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: VY4 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: VY4 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: VY4's revenue (7.2% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: VY4's revenue (7.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if VY4's Return on Equity is forecast to be high in 3 years time

SNDL Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

No longer forecast to breakeven

Forecast breakeven date moved forward to 2023

Forecast breakeven date moved forward to 2023

Forecast breakeven date moved forward to 2023

SNDL Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Recent updates

SNDL Inc. Announces Executive Appointments

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,200,000 shares, representing 5% for CAD 100 million.

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining majority stake in Indiva Limited (TSXV:NDVA.H).

SNDL Inc. to Report Q3, 2024 Results on Nov 05, 2024

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of 34.80% stake in Nova Cannabis Inc. (TSX:NOVC).

SNDL Inc. Appoints J. Carlo to Its Board of Directors

No longer forecast to breakeven

SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.39 million.

SNDL Inc. to Report Q2, 2024 Results on Aug 02, 2024

SNDL Inc., Annual General Meeting, Jul 30, 2024

New major risk - Revenue and earnings growth

SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.13 loss in 1Q 2023)

SNDL Inc. to Report Q1, 2024 Results on May 09, 2024

Full year 2023 earnings released: CA$0.67 loss per share (vs CA$1.46 loss in FY 2022)

SNDL Inc. to Report Fiscal Year 2023 Results on Mar 21, 2024

Third quarter 2023 earnings released: CA$0.08 loss per share (vs CA$0.41 loss in 3Q 2022)

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,100,000 shares, representing 5% for CAD 100 million.

SNDL Inc. to Report Q3, 2023 Results on Nov 13, 2023

SNDL Inc. Launches New E-Commerce Platform for its Destination Liquor Retail banner, Wine and Beyond

Second quarter 2023 earnings released: CA$0.12 loss per share (vs CA$0.31 loss in 2Q 2022)

SNDL Inc. to Report Q2, 2023 Results on Aug 14, 2023

New major risk - Share price stability

SNDL Inc. Announces Chief Financial Officer Changes

SNDL Inc., Annual General Meeting, Jul 27, 2023

SNDL Inc. to Report Q1, 2023 Results on May 15, 2023

Forecast breakeven date moved forward to 2023

Forecast breakeven date moved forward to 2023

Forecast breakeven date moved forward to 2023

SNDL Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of Substantially all of the business and assets of Superette.

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS).

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 11,800,000 shares, representing 5% for CAD 100 million.

Sundial Growers Inc. (NasdaqCM:SNDL) acquired Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

SNDL Inc. to Report Q3, 2022 Results on Nov 14, 2022

SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette.

SNDL Inc. (NasdaqCM:SNDL) entered into an arrangement agreement to acquire remaining 89.9% stake in The Valens Company Inc. (TSX:VLNS) for CAD 92.1 million.

SNDL Inc. to Report Q2, 2022 Results on Aug 12, 2022

Sundial Growers Inc. Announces Resignation of David Gordey as Chief Administrative Officer, Effective July 29, 2022

Simply Solventless Concentrates Ltd. completed the acquisition of Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc.. from Sundial Growers Inc. (NasdaqCM:SNDL).

Sundial Growers Inc. (NasdaqCM:SNDL) entered into a purchase agreement to acquire Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

Sundial Growers Inc. to Report Q1, 2022 Results on May 16, 2022

Sundial Growers Inc., Annual General Meeting, Jun 27, 2022

Sundial Growers Inc. to Report Q4, 2021 Results on Apr 14, 2022

Sundial Receives 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Rule

Simply Solventless Concentrates Ltd. entered into an asset purchase agreement to acquire Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc. from Sundial Growers Inc. (NasdaqCM:SNDL) for CAD 5 million.

An unknown byer acquired 25% stake in Pathway RX Inc from Sundial Growers Inc. (NasdaqCM:SNDL).

Sundial Growers Inc. (NasdaqCM:SNDL) entered into an agreement to acquire Inner Spirit Holdings Ltd. (CNSX:ISH) for approximately CAD 120 million.

Sundial and SAF Group Announce Strategic Capital Partnership

Sundial Growers Inc. to Report Q4, 2020 Results on Mar 17, 2021

Sundial Regains Compliance with Nasdaq Minimum Bid Price Rule

Sundial Growers Inc. has completed a Composite Units Offering in the amount of $100 million.

Sundial Growers Inc. Announces the Launch of Premium Concentrates Products Under Its Top Leaf Brand

Sundial Growers Inc. (NasdaqCM:SNDL) acquired Senior Secured Loans of Zenabis Investments Ltd for CAD 58.9 million.

Sundial Announces Concentrates Licence Agreement with Simply Solventless

Sundial Growers Transfers Listing to Extend Regaining Compliance Period

New 90-day high: €0.60

Revenue misses expectations

Third quarter 2020 earnings released: CA$0.53 loss per share

Sundial Growers Inc. Enters into Sales and Distribution Agreement with Choklat Inc

Sundial Growers Inc. to Report Q3, 2020 Results on Nov 11, 2020

David Ball, together with the senior management team of Bridge Farm Nurseries and Artemis Growth Partners reached an agreement to acquire Bridge Farm Nurseries Limited from Sundial Growers Inc. (NasdaqGS:SNDL) for CAD 90 million.

New 90-day low - €0.25

Sundial Growers Inc. has completed a Composite Units Offering in the amount of $20.048572 million.

Sundial Growers Inc. announced that it has received $18 million in funding

New 90-day low - €0.42

First half earnings released

Sundial Growers Inc. to Report Q2, 2020 Results on Aug 13, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts